Ligand profile
ZINC205346095
Virtual-screening candidate from ZINC.
Bound to: VK055_4666 — guaA GMP synthetase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC205346095- UniProt (similar protein)
Q8IJR9- Tanimoto
- 0.525
- Target protein
- VK055_4666
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 214.4
- −1 ≤ LogP ≤ 5 -2.83
- MW ≤ 500 Da 369.2
- LogP ≤ 5 -2.83
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 214.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=c1[nH]c(=O)n([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)cc1[N+](=O)[O-]O=c1[nH]c(=O)n([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)cc1[N+](=O)[O-]
InChI=1S/C9H12N3O11P/c13-5-4(2-22-24(19,20)21)23-8(6(5)14)11-1-3(12(17)18)7(15)10-9(11)16/h1,4-6,8,13-14H,2H2,(H,10,15,16)(H2,19,20,21)/t4-,5-,6-,8-/m1/s1InChI=1S/C9H12N3O11P/c13-5-4(2-22-24(19,20)21)23-8(6(5)14)11-1-3(12(17)18)7(15)10-9(11)16/h1,4-6,8,13-14H,2H2,(H,10,15,16)(H2,19,20,21)/t4-,5-,6-,8-/m1/s1
HXXCOPAUDCGLQO-UAKXSSHOSA-NHXXCOPAUDCGLQO-UAKXSSHOSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- XMP
- Homolog
- Q8IJR9
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC205346095 →
- ZINC ZINC20 ZINC205346095 →
- UniProt UniProt Q8IJR9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC205346095”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4666.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).